Company at a Glance
VIDEO
📊 Get full analytics about Astellas Pharma
Sign up for free
or
log in
🔓 Unlock our free guide: "The Checklist Value Investor — A Smarter Way to Pick Stocks"
Price
Overview
Astellas Pharma is a Japanese pharmaceutical company that was created in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company focuses on the research, development, and commercialization of pharmaceutical products in a variety of therapeutic areas, including immunology, oncology, and urology.
What is special about the company?
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
💡 Learn smarter stock picks with "The Checklist Value Investor — A Smarter Way to Pick Stocks"
VGhlcmUgYX JlIGEgZmV3 IHRoaW5ncy B0aGF0IGFy ZSBzcGVjaW FsIGFib3V0 IEFzdGVsbG FzIFBoYXJt YSBhcyBhIG NvbXBhbnk6 PGJyPjEuIF N0cmVuZ3Ro IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudDog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIH N0cm9uZyBm b2N1cyBvbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIHdpdG ggYSBzaWdu aWZpY2FudC Bwb3J0aW9u IG9mIGl0cy ByZXZlbnVl cyBiZWluZy BpbnZlc3Rl ZCBpbiB0aG lzIGFyZWEu IFRoaXMgaG FzIGFsbG93 ZWQgdGhlbS B0byBkZXZl bG9wIGlubm 92YXRpdmUg bWVkaWNpbm VzIGFuZCB0 cmVhdG1lbn RzIGZvciBh IHdpZGUgcm FuZ2Ugb2Yg aWxsbmVzc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgcHJlc2Vu Y2U6IEFzdG VsbGFzIFBo YXJtYSBpcy BhIHRydWx5 IGdsb2JhbC Bjb21wYW55 LCB3aXRoIG xvY2F0aW9u cyBhbmQgb3 BlcmF0aW9u cyBpbiBvdm VyIDUwIGNv dW50cmllcy B3b3JsZHdp ZGUuIFRoaX MgaGFzIGVu YWJsZWQgdG hlbSB0byBy ZWFjaCBhIG Jyb2FkIG1h cmtldCBhbm QgcHJvdmlk ZSB0aGVpci Bwcm9kdWN0 cyBhbmQgc2 VydmljZXMg dG8gYSBkaX ZlcnNlIHJh bmdlIG9mIH BhdGllbnQg cG9wdWxhdG lvbnMuPGJy PjMuIFBhdG llbnQtY2Vu dHJpYyBhcH Byb2FjaDog QXN0ZWxsYX MgUGhhcm1h IHByaW9yaX RpemVzIHRo ZSBuZWVkcy BhbmQgd2Vs bC1iZWluZy BvZiBwYXRp ZW50cyBhYm 92ZSBhbGwg ZWxzZS4gVG hleSBzdHJp dmUgdG8gdW 5kZXJzdGFu ZCB0aGUgbm VlZHMgb2Yg cGF0aWVudH MgYW5kIHdv cmsgdG8gZG V2ZWxvcCB0 cmVhdG1lbn RzIHRoYXQg YWRkcmVzcy B0aGVpciBz cGVjaWZpYy Bjb25kaXRp b25zLjxicj 40LiBDb21t aXRtZW50IH RvIHN1c3Rh aW5hYmlsaX R5OiBUaGUg Y29tcGFueS BoYXMgYSBz dHJvbmcgY2 9tbWl0bWVu dCB0byBzdX N0YWluYWJp bGl0eSwgaW 1wbGVtZW50 aW5nIGVjby 1mcmllbmRs eSBwcmFjdG ljZXMgYW5k IGluaXRpYX RpdmVzIGlu IGl0cyBvcG VyYXRpb25z IGFuZCBwcm 9kdWN0aW9u IHByb2Nlc3 Nlcy4gVGhl eSBhbHNvIH dvcmsgdG8g ZW5zdXJlIG V0aGljYWwg YW5kIHJlc3 BvbnNpYmxl IGJ1c2luZX NzIHByYWN0 aWNlcy48Yn I+NS4gQ29s bGFib3JhdG l2ZSBwYXJ0 bmVyc2hpcH M6IEFzdGVs bGFzIFBoYX JtYSBiZWxp ZXZlcyBpbi Bjb2xsYWJv cmF0aW9uIG FuZCB3b3Jr aW5nIHdpdG ggb3RoZXIg Y29tcGFuaW VzLCBvcmdh bml6YXRpb2 5zLCBhbmQg aW5kaXZpZH VhbHMgdG8g YWNoaWV2ZS B0aGVpciBt aXNzaW9uIG 9mIGltcHJv dmluZyB0aG UgbGl2ZXMg b2YgcGF0aW VudHMuIFRo ZXkgaGF2ZS Bmb3JtZWQg cGFydG5lcn NoaXBzIHdp dGggdmFyaW 91cyBhY2Fk ZW1pYyBpbn N0aXR1dGlv bnMsIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMsIGFu ZCBvdGhlci BwaGFybWEg Y29tcGFuaW VzIHRvIGFk dmFuY2UgaG VhbHRoY2Fy ZSBpbm5vdm F0aW9uLjxi cj42LiBDb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Oi BBc3RlbGxh cyBQaGFybW EgaXMgY29t bWl0dGVkIH RvIGdpdmlu ZyBiYWNrIH RvIHRoZSBj b21tdW5pdH kgYW5kIGlt cHJvdmluZy BwZW9wbGUn cyBsaXZlcy B0aHJvdWdo IGl0cyBjb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5IG luaXRpYXRp dmVzLiBUaG lzIGluY2x1 ZGVzIGludm VzdGluZyBp biBlZHVjYX Rpb24sIHBy b21vdGluZy BlbXBsb3ll ZSBkaXZlcn NpdHkgYW5k IGluY2x1c2 lvbiwgYW5k IHN1cHBvcn RpbmcgbG9j YWwgY29tbX VuaXRpZXMu
What the company's business model?
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
⚡ Instantly access "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!
QXN0ZWxsYX MgUGhhcm1h IGlzIGEgZ2 xvYmFsIHBo YXJtYWNldX RpY2FsIGNv bXBhbnkgdG hhdCBmb2N1 c2VzIG9uIG RldmVsb3Bp bmcsIG1hbn VmYWN0dXJp bmcsIGFuZC BtYXJrZXRp bmcgaW5ub3 ZhdGl2ZSBh bmQgaGlnaC 1xdWFsaXR5 IG1lZGljaW 5lcyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiB2YXJpb3 VzIGRpc2Vh c2VzIGFuZC Bjb25kaXRp b25zLiBJdH MgYnVzaW5l c3MgbW9kZW wgcmV2b2x2 ZXMgYXJvdW 5kIHRoZSBm b2xsb3dpbm cga2V5IGFz cGVjdHM6PG JyPjEuIFJl c2VhcmNoIG FuZCBEZXZl bG9wbWVudC AoUiZEKTog QXN0ZWxsYX MgUGhhcm1h IGludmVzdH MgaGVhdmls eSBpbiBSJk QgdG8gZGlz Y292ZXIgYW 5kIGRldmVs b3AgbmV3IG RydWdzIGFu ZCB0cmVhdG 1lbnRzLiBU aGUgY29tcG FueSBoYXMg YSBnbG9iYW wgbmV0d29y ayBvZiByZX NlYXJjaCBj ZW50ZXJzIG FuZCBlbXBs b3lzIGEgdG VhbSBvZiBz Y2llbnRpc3 RzIGFuZCBy ZXNlYXJjaG VycyB3aG8g d29yayBjb2 xsYWJvcmF0 aXZlbHkgdG 8gaWRlbnRp ZnkgYW5kIG RldmVsb3Ag cG90ZW50aW FsIGRydWcg Y2FuZGlkYX Rlcy48YnI+ Mi4gU3RyYX RlZ2ljIFBh cnRuZXJzaG lwcyBhbmQg Q29sbGFib3 JhdGlvbnM6 IEFzdGVsbG FzIFBoYXJt YSBjb2xsYW JvcmF0ZXMg d2l0aCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG FjYWRlbWlj IGluc3RpdH V0aW9ucywg YW5kIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMgdG8g YWNjZXNzIG 5ldyB0ZWNo bm9sb2dpZX MsIHNoYXJl IGtub3dsZW RnZSwgYW5k IGFkdmFuY2 UgaXRzIFIm RCBlZmZvcn RzLiBUaGUg Y29tcGFueS BhbHNvIHNl ZWtzIHRvIG FjcXVpcmUg b3IgbGljZW 5zZSBwcm9t aXNpbmcgY2 9tcG91bmRz IGFuZCB0ZW Nobm9sb2dp ZXMgZnJvbS BleHRlcm5h bCBzb3VyY2 VzIHRvIGV4 cGFuZCBpdH MgcHJvZHVj dCBwaXBlbG luZS48YnI+ My4gTWFudW ZhY3R1cmlu ZyBhbmQgU3 VwcGx5IENo YWluOiBBc3 RlbGxhcyBQ aGFybWEgaG FzIGEgZ2xv YmFsIG1hbn VmYWN0dXJp bmcgYW5kIH N1cHBseSBu ZXR3b3JrIH RoYXQgcHJv ZHVjZXMgYW 5kIGRpc3Ry aWJ1dGVzIG l0cyBwcm9k dWN0cyB0by B2YXJpb3Vz IG1hcmtldH Mgd29ybGR3 aWRlLiBUaG UgY29tcGFu eSBlbnN1cm VzIHRoZSBo aWdoZXN0IH N0YW5kYXJk cyBvZiBxdW FsaXR5IGFu ZCBjb21wbG lhbmNlIGlu IGl0cyBtYW 51ZmFjdHVy aW5nIHByb2 Nlc3NlcyB0 byBtZWV0IH JlZ3VsYXRv cnkgcmVxdW lyZW1lbnRz Ljxicj40Li BNYXJrZXRp bmcgYW5kIF NhbGVzOiBB c3RlbGxhcy BQaGFybWEg bWFya2V0cy BpdHMgcHJv ZHVjdHMgdG hyb3VnaCBh IG5ldHdvcm sgb2Ygc2Fs ZXMgcmVwcm VzZW50YXRp dmVzIHRvIG hlYWx0aGNh cmUgcHJvZm Vzc2lvbmFs cyBhbmQgaG 9zcGl0YWxz LiBUaGUgY2 9tcGFueSB1 c2VzIHZhcm lvdXMgbWFy a2V0aW5nIH N0cmF0ZWdp ZXMgdG8gcm Fpc2UgYXdh cmVuZXNzIG FuZCBwcm9t b3RlIGl0cy Bwcm9kdWN0 cywgaW5jbH VkaW5nIHRy YWRpdGlvbm FsIGFkdmVy dGlzaW5nLC BtZWRpY2Fs IGNvbmZlcm VuY2VzLCBh bmQgZWR1Y2 F0aW9uYWwg cHJvZ3JhbX MuPGJyPjUu IEdsb2JhbC BHcm93dGgg YW5kIEV4cG Fuc2lvbjog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIG ZvY3VzZWQg YXBwcm9hY2 ggdG8gZXhw YW5kIGl0cy BnbG9iYWwg Zm9vdHByaW 50IGJ5IGVu dGVyaW5nIG 5ldyBtYXJr ZXRzLCBwYX J0aWN1bGFy bHkgaW4gZW 1lcmdpbmcg ZWNvbm9taW VzLCBhbmQg ZGl2ZXJzaW Z5aW5nIGl0 cyBwcm9kdW N0IHBvcnRm b2xpby4gVG hlIGNvbXBh bnkgYWxzby BzZWVrcyB0 byBlc3RhYm xpc2ggcGFy dG5lcnNoaX BzIHdpdGgg bG9jYWwgY2 9tcGFuaWVz IHRvIHN0cm VuZ3RoZW4g aXRzIHByZX NlbmNlIGlu IGRpZmZlcm VudCByZWdp b25zLjxicj 42LiBDb3Jw b3JhdGUgU2 9jaWFsIFJl c3BvbnNpYm lsaXR5IChD U1IpOiBBc3 RlbGxhcyBQ aGFybWEgaX MgY29tbWl0 dGVkIHRvIG dpdmluZyBi YWNrIHRvIH NvY2lldHkg YW5kIGZvc3 RlcmluZyBz dXN0YWluYW JsZSBncm93 dGggaW4gdG hlIGNvbW11 bml0aWVzIG l0IHNlcnZl cy4gVGhlIG NvbXBhbnkn cyBDU1IgcH JvZ3JhbXMg Zm9jdXMgb2 4gc3VwcG9y dGluZyBoZW FsdGhjYXJl IGluaXRpYX RpdmVzLCBw cm9tb3Rpbm cgZW52aXJv bm1lbnRhbC BzdXN0YWlu YWJpbGl0eS wgYW5kIGlu dmVzdGluZy BpbiBsb2Nh bCBjb21tdW 5pdGllcy48 YnI+SW4gc3 VtbWFyeSwg QXN0ZWxsYX MgUGhhcm1h J3MgYnVzaW 5lc3MgbW9k ZWwgcmV2b2 x2ZXMgYXJv dW5kIGludm VzdGluZyBp biBSJkQsIH N0cmF0ZWdp YyBwYXJ0bm Vyc2hpcHMg YW5kIGNvbG xhYm9yYXRp b25zLCBhIG dsb2JhbCBt YW51ZmFjdH VyaW5nIGFu ZCBzdXBwbH kgY2hhaW4s IG1hcmtldG luZyBhbmQg c2FsZXMsIG dsb2JhbCBn cm93dGggYW 5kIGV4cGFu c2lvbiwgYW 5kIGNvcnBv cmF0ZSBzb2 NpYWwgcmVz cG9uc2liaW xpdHkuIEJ5 IGZvbGxvd2 luZyB0aGlz IG1vZGVsLC B0aGUgY29t cGFueSBhaW 1zIHRvIG9m ZmVyIGlubm 92YXRpdmUg YW5kIGhpZ2 gtcXVhbGl0 eSBtZWRpY2 luZXMgdG8g aW1wcm92ZS BwYXRpZW50 IG91dGNvbW VzIGFuZCBj cmVhdGUgbG 9uZy10ZXJt IHZhbHVlIG ZvciBpdHMg c3Rha2Vob2 xkZXJzLg==
Interesting facts about the company
📈 Want to read more about Astellas Pharma?
Sign up for free
or
log in
🆓 Discover "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free eBook!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvS1 dxd2ZzYzh1 dVgyZmh6NX h2TUIud2Vi cCIgYWx0PS JBc3RlbGxh cyBQaGFybW EiIHRpdGxl PSJBc3RlbG xhcyBQaGFy bWEiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k4ggV2FudC B0byByZWFk IG1vcmUgYW JvdXQgQXN0 ZWxsYXMgUG hhcm1hPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TpSBHZXQg b3VyIGZyZW UgZUJvb2sg bm93OiA8aT 4iVGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrcyI8L2k+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBNUzRn UVhOMFpXIH hzWVhNZ1VH aGggY20xaE lIZGhjeSBC bWIzSnRaV1 FnIGFXNGdN akF3TlMgQj BhSEp2ZFdk byBJSFJvWl NCdFpYIEpu WlhJZ2IyWW cgZEhkdklF cGhjRyBGdV pYTmxJSEJv IFlYSnRZV0 5sZFggUnBZ MkZzSUdOdi BiWEJoYm1s bGN5IHdnV1 dGdFlXNXYg ZFdOb2FTQl FhRyBGeWJX RmpaWFYwIG FXTmhiQ0JE YnkgNGdZVz VrSUVaMSBh bWx6WVhkaE lGIEJvWVhK dFlXTmwgZF hScFkyRnNJ RSBOdkxqeG ljajR5IExp QlVhR1VnWT IgOXRjR0Z1 ZWVLQSBtWE 1nWjJ4dllt IEZzSUdobF lXUnggZFdG eWRHVnljeS BCcGN5QnNi Mk5oIGRHVm tJR2x1SUYg UnZhM2x2TE NCSyBZWEJo Yml3Z1luIF YwSUdsMElH RnMgYzI4Z2 FHRnpJRyBF Z2MybG5ibW xtIGFXTmhi blFnY0ggSm xjMlZ1WTJV ZyBhVzRnYj NSb1pYIEln WTI5MWJuUn kgYVdWeklI TjFZMiBnZ1 lYTWdkR2hs IElGVnVhWF JsWkMgQlRk R0YwWlhNcy BJRVYxY205 d1pTIHdnWV c1a0lFRnog YVdFdVBHSn lQaiBNdUlF RnpkR1ZzIG JHRnpJSE53 WlcgTnBZV3 hwZW1WeiBJ R2x1SUdSbG RtIFZzYjNC cGJtY2cgWV c1a0lHMWhi biBWbVlXTj BkWEpwIGJt Y2diV1ZrYV cgTnBibVZ6 SUdsdSBJSE 5sZG1WeVlX IHdnZEdobG NtRncgWlhW MGFXTWdZWC BKbFlYTXNJ R2x1IFkyeD FaR2x1Wnkg QjFjbTlzYj JkNSBMQ0J2 Ym1OdmJHID luZVN3Z2FX MXQgZFc1dm JHOW5lUyB3 Z1lXNWtJR2 x1IFptVmpk R2x2ZFggTW daR2x6WldG eiBaWE11UE dKeVBqIFF1 SUZSb1pTQn UgWVcxbElF RnpkRyBWc2 JHRnpJR2x6 IElHUmxjbW wyWlcgUWda bkp2YlNCMC BhR1VnUjNK bFpXIHNnZD I5eVpITWcg WVhOMFpYSX NJRyAxbFlX NXBibWNnIG MzUmhjaXdn WVcgNWtJR3 h2WjI5eiBM Q0J0WldGdW FXIDVuSUhk dmNtUWcgYj NJZ2JXVnpj MiBGblpTd2 djbVZ3IGNt VnpaVzUwYV cgNW5JSFJv WlNCaiBiMj F3WVc1NTRv IENaY3lCam IyMXQgYVhS dFpXNTBJSC BSdklITm9h VzVwIGJtY2 dZU0JzYVcg ZG9kQ0J2Ym lCdSBaWGNn YVdSbFlYIE 1nWVc1a0lH SnkgYVc1bm FXNW5JSCBS b1pXMGdkRz hnIGJHbG1a UzQ4WW4gSS tOUzRnU1c0 ZyBZV1JrYV hScGIyIDRn ZEc4Z2NHaG ggY20xaFky VjFkRyBsal lXeHpMQ0JC IGMzUmxiR3 hoY3kgQmhi SE52SUdoaC BjeUJoSUhO MGNtIDl1Wn lCbWIyTjEg Y3lCdmJpQn laVyBkbGJt VnlZWFJwIG RtVWdiV1Zr YVcgTnBibV VnWVc1ayBJ R2x6SUdGam RHIGwyWld4 NUlHbHUgZG 1WemRHbHVa eSBCcGJpQn pkR1Z0IElH TmxiR3dnY2 0gVnpaV0Z5 WTJnZyBZVz VrSUhSbFky IGh1YjJ4dl oza3UgUEdK eVBqWXVJRS BGemRHVnNi R0Z6IElHaG hjeUJpWlcg VnVJSEpsWT I5biBibWw2 WldRZ1ptID l5SUdsMGN5 QnogZFhOMF lXbHVZVyBK cGJHbDBlU0 JsIFptWnZj blJ6TEMgQn BibU5zZFdS cCBibWNnWW 1WcGJtIGNn Ym1GdFpXUW cgYjI1bElH OW1JSCBSb1 pTQlhiM0pz IFpPS0FtWE 1nVFcgOXpk Q0JGZEdocC BZMkZzSUVO dmJYIEJoYm 1sbGN5Qmkg ZVNCMGFHVW dSWCBSb2FY TndhR1Z5IF pTQkpibk4w YVggUjFkR1 VnWm05eSBJ SE5sZG1WeV lXIHdnWTI5 dWMyVmogZF hScGRtVWdl VyBWaGNuTX VQR0p5IFBq Y3VJRlJvWl MgQmpiMjF3 WVc1NSBJR2 x6SUdOdmJX IDFwZEhSbF pDQjAgYnlC bmFYWnBibS BjZ1ltRmph eUIwIGJ5Qj BhR1VnWTIg OXRiWFZ1YV hScCBaWE1n YVhRZ2MyIF Z5ZG1WeklI Um8gY205MV oyZ2dkbSBG eWFXOTFjeU JqIGIzSndi M0poZEcgVW djMjlqYVdG cyBJSEpsYz NCdmJuIE5w WW1sc2FYUj UgSUhCeWIy ZHlZVyAxek xDQnBibU5z IGRXUnBibW NnYzMgVndj Rzl5ZEdsdS BaeUJvWldG c2RHIGhqWV hKbElHRmog WTJWemN5Qm hibSBRZ1pX UjFZMkYwIG FXOXVJR2x1 YVggUnBZWF JwZG1WeiBM anhpY2o0NE xpIEJKYmlB eU1EQTQgTE NCQmMzUmxi RyB4aGN5Qm laV05oIGJX VWdkR2hsSU cgWnBjbk4w SUhCbyBZWE p0WVdObGRY IFJwWTJGc0 lHTnYgYlhC aGJua2dkRy A4Z2NHRnlk RzVsIGNpQj NhWFJvSUgg Um9aU0JKYm 5SbCBjbTVo ZEdsdmJtIE ZzSUZOd1lX TmwgSUZOMF lYUnBiMiA0 Z0tFbFRVeW tnIFRtRjBh Vzl1WVcgd2 dUR0ZpYjNK aCBkRzl5ZV N3Z1kyIDl1 WkhWamRHbH UgWnlCeVpY TmxZWCBKam FDQnZiaUJo IGJuUnBMV0 5oYm0gTmxj aUJrY25Wbi BjeUJwYmlC dGFXIE55Yj JkeVlYWnAg ZEhrdVBHSn lQaiBrdUlF RnpkR1ZzIG JHRnpJR2ho Y3kgQmhJSE 4wY205dSBa eUJ3YVhCbG JHIGx1WlNC dlppQnUgWl hjZ1lXNWtJ RyBsdWJtOT JZWFJwIGRt VWdkSEpsWV ggUnRaVzUw Y3l3ZyBkMm wwYUNCdmRt IFZ5SURjd0 lHTnMgYVc1 cFkyRnNJSC BSeWFXRnNj eUJqIGRYSn laVzUwYkgg a2dkVzVrWl hKMyBZWGtn ZDI5eWJHIF IzYVdSbExq eGkgY2o0eE 1DNGdWRyBo bElHTnZiWE JoIGJua2dh R0Z6SUggSm xZMlZwZG1W ayBJRzUxYl dWeWIzIFZ6 SUdGM1lYSm sgY3lCaGJt UWdjbSBWam IyZHVhWFJw IGIyNXpJR1 p2Y2kgQnBk SE1nY0hKdi BaSFZqZEhN c0lIIEpsYz JWaGNtTm8g TENCaGJtUW dZbiBWemFX NWxjM01nIG IzQmxjbUYw YVcgOXVjeX dnYVc1aiBi SFZrYVc1bk lHIEpsYVc1 bklHNWggYl dWa0lHOXVa UyBCdlppQj BhR1VnIFZH OXdJRFV3SU UgTnZiWEJo Ym1sbCBjeU JtYjNJZ1JH IGwyWlhKem FYUjUgSUdK NUlFUnBkbS BWeWMybDBl VWx1IFl5ND 0KICAgICAg ICA8L3NwYW 4+CiAgICAg ICAgCiAgIC AgICAg
See Company Q&A
📊 Get full analytics about Astellas Pharma
Sign up for free
or
log in
📚 Your free copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks" is waiting
